Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001789769-25-000019
Filing Date
2025-03-04
Accepted
2025-03-04 07:44:30
Documents
7
Effectiveness Date
2025-03-04

Document Format Files

Seq Description Document Type Size
1 S-8 s-8evergreenq1x25.htm S-8 51231
2 EX-FILING FEES exhibit107feetableinstil.htm EX-FILING FEES 4610
3 EX-5.1 a51opinioninstil-formsx8.htm EX-5.1 4960
4 EX-23.1 s-8ex231consentofdeloittet.htm EX-23.1 1786
5 a51opinioninstil-formsx8001.jpg GRAPHIC 240285
6 a51opinioninstil-formsx8002.jpg GRAPHIC 61297
7 exhibit107feetableinstil001.jpg GRAPHIC 216475
  Complete submission text file 0001789769-25-000019.txt   777447
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285526 | Film No.: 25701575
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)